Published in Can Respir J on February 26, 2010
Numb chin syndrome as the initial presentation of posttransplant lymphoproliferative disorder. Proc (Bayl Univ Med Cent) (2012) 0.77
International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant (2006) 4.95
Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet (1998) 4.69
Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer (2003) 2.64
Registry of the International Society for Heart and Lung Transplantation: twenty-third official adult lung and heart-lung transplantation report--2006. J Heart Lung Transplant (2006) 1.78
Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs (2007) 1.76
Does lung transplantation prolong life? A comparison of survival with and without transplantation. J Heart Lung Transplant (1998) 1.47
Prospective registry-based observational cohort study of the long-term risk of malignancies in renal transplant patients treated with mycophenolate mofetil. Am J Transplant (2005) 1.33
Bronchogenic carcinoma after lung transplantation: frequency, clinical characteristics, and imaging findings. Radiology (2002) 1.12
High frequency of bronchogenic carcinoma after single-lung transplantation. J Heart Lung Transplant (2006) 1.10
Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant (1997) 1.08
Cigarette smoking in renal transplant recipients. J Am Soc Nephrol (2000) 1.07
Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant (2006) 1.01
Bronchogenic carcinoma complicating lung transplantation. J Heart Lung Transplant (2001) 1.00
Anti-tumor activity of mycophenolate mofetil against human and mouse tumors in vivo. Int J Cancer (1994) 0.98
Incidence of malignancies in heart and/or lung transplant recipients: a single-institution experience. J Heart Lung Transplant (2007) 0.97
Immunosuppressive therapy after human lung transplantation. Eur Respir J (2004) 0.96
Short-term outcome of chronic immunosuppression on the development of breast lesions in premenopausal heart and lung transplant patients. J Surg Res (1998) 0.89
Results of heart transplantation in patients with preexisting malignancies. Am J Cardiol (1997) 0.89
Long-term follow-up of hearttransplant recipients with pre-transplant malignancies. Tex Heart Inst J (2006) 0.81
Development of malignancy following lung transplantation. Transplantation (2006) 0.81
Mycophenolate mofetil increases adhesion capacity of tumor cells in vitro. Transplantation (2003) 0.79
Vital signs after cardiac arrest following withdrawal of life-sustaining therapy: a multicenter prospective observational study. Crit Care Med (2014) 5.07
Family satisfaction with care in the intensive care unit: results of a multiple center study. Crit Care Med (2002) 3.36
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med (2013) 2.68
Decision-making in the ICU: perspectives of the substitute decision-maker. Intensive Care Med (2002) 2.09
Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology (2010) 2.02
Predictors of survival following in-hospital adult cardiopulmonary resuscitation. CMAJ (2002) 1.92
Defining priorities for improving end-of-life care in Canada. CMAJ (2010) 1.59
The relationship between organizational culture and family satisfaction in critical care. Crit Care Med (2012) 1.52
The development and validation of a novel questionnaire to measure patient and family satisfaction with end-of-life care: the Canadian Health Care Evaluation Project (CANHELP) Questionnaire. Palliat Med (2010) 1.26
Assessing the use of health-related quality of life measures in the routine clinical care of lung-transplant patients. Qual Life Res (2010) 1.15
Generic immunosuppression in solid organ transplantation: a Canadian perspective. Transplantation (2012) 1.10
A trial of valganciclovir prophylaxis for cytomegalovirus prevention in lung transplant recipients. Am J Transplant (2005) 1.03
Most critically ill patients are perceived to die in comfort during withdrawal of life support: a Canadian multicentre study. Can J Anaesth (2004) 1.03
Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Crit Care Med (2010) 1.00
An international survey of cytomegalovirus management practices in lung transplantation. Transplantation (2010) 0.97
Predictors of bacteraemia and mortality in patients with acute liver failure. Intensive Care Med (2009) 0.96
Diagnostic evaluation and management of chronic thromboembolic pulmonary hypertension: a clinical practice guideline. Can Respir J (2010) 0.92
An assessment of the effects of Iyengar yoga practice on the health-related quality of life of patients with chronic respiratory diseases: a pilot study. Can Respir J (2013) 0.90
Quantification of HBV covalently closed circular DNA from liver tissue by real-time PCR. Methods Mol Med (2004) 0.90
Effects of nocturnal noninvasive mechanical ventilation on heart rate variability of patients with advanced COPD. Chest (2007) 0.90
Improvement in health-related quality of life after lung transplantation. Can Respir J (2009) 0.89
Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients. J Heart Lung Transplant (2011) 0.87
A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation. J Heart Lung Transplant (2007) 0.87
A systematic review and meta-analysis to assess patient-reported outcomes after lung cancer surgery. ScientificWorldJournal (2013) 0.86
Clinical significance of intrahepatic hepatitis B virus covalently closed circular DNA in chronic hepatitis B patients who received cytotoxic chemotherapy. Blood (2005) 0.86
Quantification of carbonic anhydrase gene expression in ventricle of hypertrophic and failing human heart. BMC Cardiovasc Disord (2013) 0.83
Primary Kaposi sarcoma of the subcutaneous tissue. World J Surg Oncol (2008) 0.83
Emergence of Aspergillus calidoustus infection in the era of posttransplantation azole prophylaxis. Transplantation (2012) 0.82
Organizational and safety culture in Canadian intensive care units: relationship to size of intensive care unit and physician management model. J Crit Care (2011) 0.82
Canadian nurses' and respiratory therapists' perspectives on withdrawal of life support in the intensive care unit. J Crit Care (2005) 0.82
Treatment of hepatitis C in potential lung transplant candidates. Transplantation (2007) 0.81
Does donor cause of death affect the outcome of lung transplantation? J Thorac Cardiovasc Surg (2002) 0.81
Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment. Heart Fail Rev (2015) 0.80
The construct validity of the health utilities index mark 3 in assessing health status in lung transplantation. Health Qual Life Outcomes (2010) 0.79
Methicillin-resistant Staphylococcus aureus infection after lung transplantation: 5-year review of clinical and molecular epidemiology. J Heart Lung Transplant (2009) 0.79
The use of patient-reported outcomes becomes standard practice in the routine clinical care of lung-heart transplant patients. Patient Relat Outcome Meas (2010) 0.78
Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance. J Heart Lung Transplant (2006) 0.78
Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment. Pediatr Transplant (2014) 0.78
Patient-reported outcome 2 years after lung transplantation: does the underlying diagnosis matter? Patient Relat Outcome Meas (2012) 0.77
A case of lamin A/C mutation cardiomyopathy with overlap features of ARVC: a critical role of genetic testing. Int J Cardiol (2013) 0.77
Selective antegrade cerebral perfusion during aortic arch surgery confers survival and neuroprotective advantages. J Thorac Cardiovasc Surg (2010) 0.76
Effect of melanoma on immune function in the regional lymph node basin. Clin Cancer Res (2008) 0.76
Systemic inflammatory response syndrome, the link between subarachnoid hemorrhage and caloric balance. JPEN J Parenter Enteral Nutr (2009) 0.75
Noninvasive ventilation practice patterns for acute respiratory failure in Canadian tertiary care centres: A descriptive analysis. Can Respir J (2015) 0.75
Large left atrial myxoma causing mitral valve obstruction: diagnosis by computed tomography. J Card Surg (2006) 0.75
Patients with Active Luminal Crohn's Disease Have Evidence of Significant Functional and Clinical Pulmonary Involvement. Inflamm Bowel Dis (2015) 0.75
Lung and heart lung transplantation at the University of Alberta 1986-2010. Clin Transpl (2010) 0.75
Incidence of milrinone blood levels outside the therapeutic range and their relevance in children after cardiac surgery for congenital heart disease. Intensive Care Med (2013) 0.75
A comparative analysis of outcome after heart transplantation in patients aged 60 years and older: the University of Alberta experience. J Card Surg (2004) 0.75